206A — PRISM Biolab Co Share Price
0.000.00%
Last trade - 00:00- ¥10bn
- ¥6bn
- ¥306m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.84 | ||
| Price to Tang. Book | 2.84 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 24.31 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -32.69% | ||
| Return on Equity | -50.23% | ||
| Operating Margin | -280.65% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | 554.4 | 112.93 | 305.62 | n/a | n/a | -25.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PRISM BioLab Co Ltd is a Japan-based company mainly engaged in the drug discovery business. The Company operates through Japan drug discovery business segment. The Company builds a new drug discovery platform and develops new drugs. The Company conducts research and development of pharmaceuticals using their owned drug discovery platform technology PepMetics technology. There are two business models. The in-house development business is engaged in the select of drug discovery targets and creates programs in-house. The joint development business creates programs using their owned technology to target drug discovery targets for pharmaceutical companies.
Directors
- Last Annual
- September 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 2nd, 2012
- Public Since
- July 2nd, 2024
- No. of Shareholders
- 4,265
- No. of Employees
- 27
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 36,671,600
- Address
- Shonan I Park, 2-26-1, Muraoka-Higashi, FUJISAWA-SHI, 251-8555
- Web
- https://prismbiolab.com/
- Phone
- +81 466538383
- Auditors
- KPMG AZSA LLC
Upcoming Events for 206A
Dividend For 206A.T - 0.0000 JPY
Similar to 206A
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the PRISM Biolab Co share price?
As of Today at 22:44 UTC, shares in PRISM Biolab Co are trading at ¥258. This share price information is delayed by 15 minutes.
How has the PRISM Biolab Co share price performed this year?
Shares in PRISM Biolab Co last closed at ¥258 and the price had moved by over the past 365 days. In terms of relative price strength the PRISM Biolab Co share price has matched the Nikkei 225 Index by over the past year.
What are the analyst and broker recommendations for PRISM Biolab Co?
There is no consensus recommendation for this security.
Find out moreWhat is the PRISM Biolab Co dividend yield?
PRISM Biolab Co does not currently pay a dividend.
Does PRISM Biolab Co pay a dividend?
PRISM Biolab Co does not currently pay a dividend.
When does PRISM Biolab Co next pay dividends?
PRISM Biolab Co does not currently pay a dividend.
How do I buy PRISM Biolab Co shares?
To buy shares in PRISM Biolab Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PRISM Biolab Co?
As of the previous close price of ¥258, shares in PRISM Biolab Co had a market capitalisation of ¥10bn.
Where are PRISM Biolab Co shares listed?
Here are the trading details for PRISM Biolab Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 206A
What kind of share is PRISM Biolab Co?
Based on an overall assessment of its quality, value and momentum PRISM Biolab Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PRISM Biolab Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the PRISM Biolab Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PRISM Biolab Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -13.64%.
As of the last closing price of ¥258, shares in PRISM Biolab Co were trading -29.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PRISM Biolab Co PE Ratio?
The PRISM Biolab Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥258.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PRISM Biolab Co?
We do not have data on PRISM Biolab Co's directors